October 11, 2018
Why would Apple, one of the greatest companies of this millennia degrade itself and go with a 1-lead ECG “watch gadget” and not a top of the line 12-lead that would have changed the face of healthcare for years to come…
October 11, 2018
Why would Apple, one of the greatest companies of this millennia degrade itself and go with a 1-lead ECG “watch gadget” and not a top of the line 12-lead that would have changed the face of healthcare for years to come…
October 8, 2018
Recently, Apple came out with their new Apple Watch Series 4 with a 1-lead ECG – a great acknowledgement that the over century old ECG is still relevant. What it did not expect was the pushback from the healthcare community who…
HealthWatch is proud to announce the opening of its Development Center in Kfar Saba, Israel
September 25, 2018
HealthWatch is proud to announce the opening of its Development Center in Kfar Saba, Israel. With cutting-edge knitting…
HealthWatch is pleased to announce the incredible results of the first patients of the HealthWatch – O2 Rehabilitation Center clinical trial.
ISRAEL21c talks with startups devising wearables to measure heart rhythm while you go about your daily routine.
February 1, 2018
Up to now, our discussions have focused mainly on smartwatches but in addition to the fitness and wellness sphere or ecosystem, the ability to transfer medical data is becoming progressively imperative with these devices. The ultimate aim of the physician is that they will be able to send a patient home with a wearable device that will be able to track their recovery. Up till now, the monitor companies have tried to place the medical parameters in the smartwatches – but why are we so fixated on the wrist? We all know that the wrist “is not the best position” for medical technology placement due to the vast lack of homogeneousness and diversity between people.
HealthWatch is pleased to announce the incredible results of the first patients of the HealthWatch – O2 Rehabilitation Center clinical trial. Additional details will be published at the end of the trial.